BTA is now a possible T/O target - not only would most major pharmas like to include this dupoly influenza drug in their own products, but more so to GSK - why pay $3 per share when you can buy it at $0.80?
BTA Price at posting:
0.0¢ Sentiment: ST Buy Disclosure: Held
